PINS delivered what the market wanted: the stock jumped 6% on earnings day and closed the week at $25.58, up 5% on the week and 16% on the month, as a wave of analyst target raises confirmed the print was good enough to move the consensus.
The analyst reaction was the clearest post-earnings signal. Virtually every firm that covered the print raised its price target — seven of ten moves were upgrades on the target — while no one changed their rating. UBS lifted to $33 and held Buy; BMO raised to $34 and kept Outperform; Barclays pushed to $31, also without a rating change. The holdouts were more instructive: Wedbush stayed at $24 with Neutral, and RBC moved only to $25, leaving its target barely above current price. The mean target across the Street now sits at $28.87, implying about 13% upside from Wednesday's close. That's a modest premium for a name where bulls cite ten consecutive quarters of double-digit user growth, AI-driven personalization, and the tvScientific acquisition opening the connected TV door. Bears counter that US market saturation is real, international monetization remains thin, and the stock is up 16% in a month on what is still a PE of roughly 11.5x — not exactly stretched, but the easy re-rating from depressed levels may be largely complete.
The positioning picture has shifted since the pre-earnings cautious tone described in the prior articles. Options traders were adding downside protection into the print; post-results, the PCR has edged back up to 0.94 — about 1.6 standard deviations above its 20-day average of 0.90 — which is now reading more as residual hedging than pre-event fear. The 52-week high on PCR is 1.15, so this is not an extreme reading. Short interest, meanwhile, has ticked fractionally higher after the print to 9.84% of free float, reversing a week of modest covering. That is a small move — under 2% on the week — and does not change the broader story: shorts have retreated materially from the mid-June peak above 11% and show no sign of rebuilding aggressively. The borrow market remains extremely loose, with availability at 1,643% — more than 16 shares available for every one currently lent out. Cost to borrow edged up 24% on the week to 0.45%, but that is still firmly in low territory, and the 52-week high utilization of only 22% confirms there is no squeeze setup here.
The founder remains a consistent seller. Benjamin Silbermann has sold approximately 46,875 shares every week for the past several weeks at prices ranging from $21.60 to $23.03, generating over $1 million per transaction. CEO William Ready also sold just over 32,000 shares at $22.81 on July 20. The 90-day net insider figure is a net sale of roughly $22.5 million. These appear to be programmatic disposals rather than conviction-driven distribution — significance scores are low — but the cadence is worth noting as the stock pushes toward levels these insiders haven't seen for some time. Elliott Management holds 5% of the company with no reported change in the most recent filing, an anchor position that has been in place since at least the March quarter.
On the broader peer tape, SNAP was the standout this week, jumping 21% after its own results — a rising-tide moment for social media broadly. YELP and TRIP went the other way, down 3% and 4% respectively on the week, suggesting the post-earnings relief is stock-specific rather than sector-wide.
The next earnings date is set for November 5. The question between now and then is whether the analyst community — which largely maintained ratings even while raising targets — finds a reason to upgrade, or whether the stock's 16% monthly run makes a fresh entry harder to justify at current multiples.
See the live data behind this article on ORTEX.
Open PINS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
